NCT00651534View on ClinicalTrials.gov

To Estimate Relative Bioavailability of 5 Formulations of Ronacaleret Given to Healthy Postmenopausal Females

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

February 29, 2008

Conditions

Osteoporosis

Interventions

DRUG

Ronacaleret

Trial Locations (1)

32127

GSK Investigational Site, Port Orange

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00651534 - To Estimate Relative Bioavailability of 5 Formulations of Ronacaleret Given to Healthy Postmenopausal Females | Biotech Hunter | Biotech Hunter